Thinking of taking your company public? Get our essential guide to a successful IPO. Download Now

Westicke Partners

Close

Kymera Therapeutics, Inc.

$200 Million Initial Public Offering

Case Study: Kymera Therapeutics, Inc.

ICR Westwicke began working with biopharmaceutical company Kymera Therapeutics in April 2020, providing strategic advice for the company’s IPO, throughout the underwriter selection process, S-1 drafting process, and four-day virtual roadshow. In August 2020, Kymera priced its upsized IPO at $20 per share.

Download the case study to learn how ICR Westwicke’s strategic advice led to a successful IPO, with shares closing up 66.3%.

Want to know how investors view your company?

Conducting a perception audit is an important way to strengthen your company and your relationships with investors. Get insight into the process in our eBook, How to Conduct a Perception Audit: A Complete Guide

Our Locations